Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?

被引：0
|
作者：
Evans, D. Gareth [1 ,2 ]
Howell, Sacha J. [2 ,3 ]
Burghel, George J. [4 ]
Forde, Claire [5 ]
Lalloo, Fiona [6 ]
Smith, Miriam J. [7 ]
Howell, Anthony [8 ]
Gandhi, Ashu [9 ]
Woodward, Emma Roisin [10 ]
机构：
[1] Univ Manchester, Victoria Univ Manchester Campus, Genom Med, Manchester, England
[2] Manchester Acad Hlth Sci Ctr, Manchester, England
[3] Christie NHS Fdn Trust, Manchester, England
[4] Manchester Univ NHS Fdn Trust, Genom Diagnost Lab, Manchester, England
[5] Cent Manchester Univ Hosp NHS Fdn Trust, Clin Genet Serv, Manchester, England
[6] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Clin Genet Serv, Manchester, England
[7] Univ Manchester, Genet Med, Manchester, England
[8] Prevent Breast Canc Ctr, Manchester, England
[9] Wythenshawe Hosp Manchester Univ Fdn Trust, Prevent Breast Canc Ctr, Manchester, England
[10] Cent Manchester NHS Fdn Trust, Manchester Ctr Genom Med, Manchester, England
来源：
JOURNAL OF MEDICAL GENETICS | 2024年 / 61卷 / 10期
关键词：
Genetic Diseases; Inborn; Gene Frequency;
D O I：
10.1136/jmg-2024-110183
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：935 / 936
页数：2
相关论文
共 50 条
  • [41] The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59
    Wilkinson, Anna N.
    Billette, Jean-Michel
    Ellison, Larry F.
    Killip, Michael A.
    Islam, Nayaar
    Seely, Jean M.
    CURRENT ONCOLOGY, 2022, 29 (08) : 5627 - 5643
  • [42] Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography A Secondary Analysis of a Randomized Clinical Trial
    Harada-Shoji, Narumi
    Suzuki, Akihiko
    Ishida, Takanori
    Zheng, Ying-Fang
    Narikawa-Shiono, Yoko
    Sato-Tadano, Akiko
    Ohta, Rie
    Ohuchi, Noriaki
    JAMA NETWORK OPEN, 2021, 4 (08)
  • [43] 18-SNP polygenic risk score does not improve breast cancer risk prediction in women aged 40-49 years in a Central European population with breast cancer risk below European average
    Oblak, T.
    Skerl, P.
    Novakovic, S.
    Narang, B.
    Blagus, R.
    Zgajnar, J.
    BREAST, 2023, 68 : S42 - S43
  • [44] Risk Factors for Breast Cancer for Women Aged 40 to 49 Years A Systematic Review and Meta-analysis
    Nelson, Heidi D.
    Zakher, Bernadette
    Cantor, Amy
    Fu, Rongwei
    Griffin, Jessica
    O'Meara, Ellen S.
    Buist, Diana S. M.
    Kerlikowske, Karla
    van Ravesteyn, Nicolien T.
    Trentham-Dietz, Amy
    Mandelblatt, Jeanne S.
    Miglioretti, Diana L.
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (09) : 635 - U79
  • [45] Randomized Controlled Trial on Effectiveness of Ultrasonography Screening for Breast Cancer in Women Aged 40-49 (J-START): Research Design
    Ohuchi, Noriaki
    Ishida, Takanori
    Kawai, Masaaki
    Narikawa, Yoko
    Yamamoto, Seiichiro
    Sobue, Tomotaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (02) : 275 - 277
  • [46] Development of a breast cancer risk assessment and primary prevention pathway for women aged 30-39 years: Views of UK primary care providers on the role of primary care
    Hindmarch, Sarah
    Gorman, Louise
    Usher-Smith, Juliet A.
    Woof, Victoria G.
    Howell, Sacha J.
    French, David P.
    PLOS ONE, 2024, 19 (09):
  • [47] Molecular genetic testing of a population based sample of women with breast cancer aged 30 years or less
    Evans, G
    Lalloo, F
    Redmond, E
    Wu, CL
    Bulman, B
    Moran, A
    O'Dair, L
    Varley, J
    Mathew, C
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S26 - S26
  • [48] Young Breast Cancer Patients Aged <40 Years and Tumor DNA Ploidy Progression
    Sennerstam, Roland B.
    Stromberg, Jan-Olov
    ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2017, 39 (02): : 57 - 68
  • [49] BREAST-CANCER DETECTION GUIDELINES FOR WOMEN AGED 40 TO 49 YEARS - RATIONALE FOR THE AMERICAN-CANCER-SOCIETY REAFFIRMATION OF RECOMMENDATIONS
    METTLIN, C
    SMART, CR
    CA-A CANCER JOURNAL FOR CLINICIANS, 1994, 44 (04) : 248 - 255
  • [50] HIGHLIGHTS OF THE EVIDENCE OF BENEFIT FOR WOMEN AGED 40-49 YEARS FROM THE 14-YEAR FOLLOW-UP OF THE BREAST-CANCER DETECTION DEMONSTRATION PROJECT
    SMART, CR
    CANCER, 1994, 74 (01) : 296 - 300
12345